TERN
NASDAQ
$52.95
Terns Pharmaceuticals Inc (TERN)
Sector:
Healthcare
Industry:
Biotechnology
Market Cap
$5.95B
FCF 5Y CAGR
+22.01%
Free Cash Flow Yield
-1.38%
Price Chart
Valuation
Market Cap$5.95B
Profitability
Gross Profit (TTM)$1M
EBITDA-$110M
EPS-$1.04
Financial Health
Free Cash Flow Yield-1.38%
Growth & Risk
FCF 5Y CAGR+22.01%
Sharpe Ratio3.07